POINT OF CARE DIAGNOSTICS

Current molecular diagnostics tests are too complex and too expensive to be used at the Point-of-Care. Leopard Biosciences is democratizing molecular diagnostics by developing instrument-free, easy-to-use, multiplex point-of-care tests with short turnaround time and low cost of goods. Leopard tests combine the simplicity of lateral flow assays with the accuracy of PCR. Our patented LEOPARD technology provides freedom-to-operate in the contested CRISPR IP space.

Founded in 07/2023.


The management team of Leopard Biosciences: